Drug News

Stay up-to-date on the latest drug news. Learn about new drug approvals, labeling changes, expanded indications, recalls, and approvals of generic formulations. These drug news updates are compiled from the latest information from Facts & Comparisons® and the U.S. Food and Drug Administration.

(Updated September 10, 2018)

The FDA has approved the following drugs:
  • Jivi (antihemophilic factor [recombinant], pegylated-aucl) lyophilized powder for intravenous solution to be used in previously treated adults and adolescents 12 years and older with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.
  • Loperamide hydrochloride/simethicone oral tablets, the generic version of Imodium Multi-Symptom Relief, to relieve symptoms of diarrhea plus bloating, pressure, cramps, and gas.
  • Pifeltro (doravirine) oral tablets, in combination with other antiretroviral agents, and Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) oral tablets to treat HIV-1 infection in adult patients with no prior antiretroviral treatment history. Delstrigo labeling includes a Boxed Warning regarding the risk of post-treatment acute exacerbation of hepatitis B.
  • Tiglutik (riluzole) oral suspension to treat amyotrophic lateral sclerosis (ALS). Riluzole is also available as an oral tablet.

More Nursing News Headlines (Pharmacy)...

Powered by